Forecast & Rating8 analysts currently cover Protara Therapeutic, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $25.71, about 571.4% upside from the current price of $3.83. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study Protara Therapeutic closely still see room for the stock to rise. Data as of Aug 12, 2026; for reference only and not investment advice.
Aug 12, 2026Price forecast
$25.71571.39%
Forecast & RatingStrong buy
8analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 7, 2026
Forecast met0.0%
Stock price$3.83
Avg. target$25.7
High target$30
Low target$20
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.